Loading clinical trials...
Loading clinical trials...
Conmana Versus Pemetrexed-based First-line Induction and Maintenance Chemotherapy in Advanced Lung Adenocarcinoma With EGFR-mutation
Conditions
Interventions
Icotinib
Chemotherapy
Locations
21
China
The First Affiliated Hospital of Anhui Medical Univercity
Hefei, Anhui, China
Chinese People's Liberation Army (PLA) General Hospital
Beijing, Beijing Municipality, China
Beijing Hospital for Chest Tumors & Tuberculosis Diseases
Beijing, Beijing Municipality, China
Xinqiao Hospital, The Third Military Medical University
Chongqing, Chongqing Municipality, China
The First Affiliated Hospital Of Guangzhou Medical Collage
Guangzhou, Guangdong, China
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
Start Date
December 1, 2012
Primary Completion Date
September 1, 2016
Completion Date
February 7, 2017
Last Updated
July 5, 2019
NCT06305754
NCT07486219
NCT05098132
NCT06731413
NCT04585750
NCT07217301
Lead Sponsor
Betta Pharmaceuticals Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions